TY - JOUR
T1 - The impact of travel distance, travel time and waiting time on health-related quality of life of diabetes patients
T2 - An investigation in six European countries
AU - Konerding, Uwe
AU - Bowen, Tom
AU - Elkhuizen, Sylvia G.
AU - Faubel, Raquel
AU - Forte, Paul
AU - Karampli, Eleftheria
AU - Mahdavi, Mahdi
AU - Malmström, Tomi
AU - Pavi, Elpida
AU - Torkki, Paulus
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Aims The effects of travel distance and travel time to the primary diabetes care provider and waiting time in the practice on health-related quality of life (HRQoL) of patients with type 2 diabetes are investigated. Research design and methods Survey data of 1313 persons with type 2 diabetes from six regions in England (274), Finland (163), Germany (254), Greece (165), the Netherlands (354), and Spain (103) were analyzed. Various multiple linear regression analyses with four different EQ-5D-3L indices (English, German, Dutch and Spanish index) as target variables, with travel distance, travel time, and waiting time in the practice as focal predictors and with control for study region, patient's gender, patient's age, patient's education, time since diagnosis, thoroughness of provider-patient communication were computed. Interactions of regions with the remaining five control variables and the three focal predictors were also tested. Results There are no interactions of regions with control variables or focal predictors. The indices decrease with increasing travel time to the provider and increasing waiting time in the provider's practice. Conclusions HRQoL of patients with type 2 diabetes might be improved by decreasing travel time to the provider and waiting time in the provider's practice.
AB - Aims The effects of travel distance and travel time to the primary diabetes care provider and waiting time in the practice on health-related quality of life (HRQoL) of patients with type 2 diabetes are investigated. Research design and methods Survey data of 1313 persons with type 2 diabetes from six regions in England (274), Finland (163), Germany (254), Greece (165), the Netherlands (354), and Spain (103) were analyzed. Various multiple linear regression analyses with four different EQ-5D-3L indices (English, German, Dutch and Spanish index) as target variables, with travel distance, travel time, and waiting time in the practice as focal predictors and with control for study region, patient's gender, patient's age, patient's education, time since diagnosis, thoroughness of provider-patient communication were computed. Interactions of regions with the remaining five control variables and the three focal predictors were also tested. Results There are no interactions of regions with control variables or focal predictors. The indices decrease with increasing travel time to the provider and increasing waiting time in the provider's practice. Conclusions HRQoL of patients with type 2 diabetes might be improved by decreasing travel time to the provider and waiting time in the provider's practice.
KW - EQ-5D
KW - Health-related quality of life
KW - Travel distance to provider
KW - Travel time to provider
KW - Type 2 diabetes mellitus
KW - Waiting time in provider's practice
UR - http://www.scopus.com/inward/record.url?scp=85012124604&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2017.01.014
DO - 10.1016/j.diabres.2017.01.014
M3 - Article
AN - SCOPUS:85012124604
SN - 0168-8227
VL - 126
SP - 16
EP - 24
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
ER -
